EUROPEAN RENAL ASSOCIATION - EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION
Services
How to use the platform
Build a poster
MANAGE ORDERS
FAQs
Contact
HOMEPAGE
Virtual Poster Gallery
PrintingOnline for Collection on-site
Accredited Training
DOI - Digital Object Identifier
What is PosterSessionOnline?
How to send your poster
How to visit the Virtual Poster Gallery
How to build a poster
How to reduce a poster to less than 2 Mb
PosterSessionOnline Image Editor
How to build a poster with our templates
How to work with a template
Templates and instructions
Discussion forum -
49th ERA-EDTA Congress
Topic -
Acid-base / Electrolytes
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
Poster:
322
Visits:
638
Title:
HYPOPHOSPHATEMIA: A SIGNIFICANT PROBLEM IN HOSPITALIZED PATIENTS
Authors:
Ravi Bansal , Sanjiv Saxena, KK Malhotra
Centre:
Pushpawati Singhania Research Institute
You must be registered to reply or comment.
HYPOPHOSPHATEMIA: A SIGNIFICANT PROBLEM IN HOSPITALIZED PATIENTS
Ravi Bansal
Thread initiator
Subspeciality
Reg:
5/4/2012 8:53:00 PM
Comment# 1
we always talk about hyperphosphatemia, but how often hypophosphatemia goes unnoticed. this has serious clinical implications which can be prevented by being more aware of this condition. any coments
Comment added on 5/4/2012 8:53:00 PM
You must be registered to reply or comment.
Most viewed poster for this congress
Poster:
424
Visits:
2636
Title:
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Glomerulonephritides: an Immunohystochemical expression analysis
Authors:
Giuseppe Coppolino ,
Centre:
Chair of Nephrology, University Magna Graecia of Catanzaro, Catanzaro, Italy
Poster most viewed in this topic
Poster:
177
Visits:
1275
Title:
RDX5791, a non-systemic NHE3 inhibitor for the treatment of fluid and sodium overload, shifts sodium excretion from urine to feces in healthy subjects
Authors:
Dominique Charmot ,
Centre:
Ardelyx Inc.
View Poster Gallery
Back to congress home
Other Congresses
About us
|
Terms and Conditions
|
Special Access